Stockreport

Celyad Oncology Provides Fourth Quarter 2022 Business Update and 2023 Outlook

Celyad Oncology SA - American Depositary Shares  (CYAD) 
US:NASDAQ Investor Relations: celyad.com/en/investors
PDF Celyad Oncology has implemented a strategic shift from an organization focused on clinical development to one fully harnessing the true potential of its proprietary tech [Read more]